Quick Picks - After declines in the first half of the week, shares of Threshold Pharmaceuticals (NASDAQ:THLD) rebounded on Thursday morning following an update on the company’s ongoing … Continue Reading
Read nowMost Popular - Thursday morning, Israeli financial newspaper, Calcalist is reporting that Teva Pharmaceuticals (NASDAQ:TEVA) and AstraZeneca (NYSE:AZN) are leading candidates among other large drug companies interested in … Continue Reading
Read nowLong Ideas - Puma Biotechnology (NYSE:PBYI) made waves last month when it uplisted to the NYSE and initiated a substantial capital raise, increasing cash and equivalents to approximately … Continue Reading
Read nowLong Ideas - The biotechnology sector is one where growth is, for the most part, fueled by a single factor: new drugs. Companies that develop the next generation … Continue Reading
Read nowLong Ideas - Endocyte (NASDAQ:ECYT) recently confirmed that the Marketing Authorization Application (MAA) filing process for vintafolide and etarfolatide in Europe is set to be completed by the end … Continue Reading
Read nowLong Ideas - While investors have been focusing their attention on palifosfamide and the upcoming phase III data, Ziopharm (NASDAQ:ZIOP) released some initial phase I data of Ad-RTS IL-12 … Continue Reading
Read nowLong Ideas - In separate press releases on Thursday morning, Celgene (NASDAQ:CELG) reported 3Q results and announced that Abraxane demonstrated a statistically significant improvement in Progression Free Survival (PFS) … Continue Reading
Read now